|
1
|
Shao Y, Sha XY, Bai YX, Quan F and Wu SL:
Effect of A disintegrin and metalloproteinase 10 gene silencing on
the proliferation, invasion and migration of the human tongue
squamous cell carcinoma cell line TCA8113. Mol Med Rep. 11:212–218.
2015.
|
|
2
|
Li H, Huang D, Gao Z, Chen Y, Zhang L and
Zheng J: Scutellarin inhibits the growth and invasion of human
tongue squamous carcinoma through the inhibition of matrix
metalloproteinase-2 and -9 and αvβ6 integrin. Int J Oncol.
42:1674–1681. 2013.PubMed/NCBI
|
|
3
|
Addeo R, Napolitano A, Montella L and
Ricciardiello F: Squamous cell carcinoma of the tongue in a female
with advanced breast cancer: A case report of an elderly patient
presenting with two types of cancer. Oncol Lett. 8:235–237.
2014.PubMed/NCBI
|
|
4
|
Chiyomaru T, Seki N, Inoguchi S, Ishihara
T, Mataki H, Matsushita R, Goto Y, Nishikawa R, Tatarano S, Itesako
T, et al: Dual regulation of receptor tyrosine kinase genes EGFR
and c-Met by the tumor-suppressive microRNA-23b/27b cluster in
bladder cancer. Int J Oncol. 46:487–496. 2015.
|
|
5
|
Jin D, Fang Y, Li Z, Chen Z and Xiang J:
Epithelial-mesenchymal transition-associated microRNAs in
colorectal cancer and drug-targeted therapies (Review). Oncol Rep.
33:515–525. 2015.
|
|
6
|
Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT
and Zhang CP: MicroRNAs contribute to the chemoresistance of
cisplatin in tongue squamous cell carcinoma lines. Oral Oncol.
46:317–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang ZC, Li YY, Wang HY, Fu S, Wang XP,
Zeng MS, Zeng YX and Shao JY: Knockdown of miR-214 promotes
apoptosis and inhibits cell proliferation in nasopharyngeal
carcinoma. PLoS One. 9:e861492014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu S, Gao Y, Huang X and Wang X:
Cantharidin exerts anti-hepatocellular carcinoma by miR-214
modulating macrophage polarization. Int J Biol Sci. 10:415–425.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ozaki T and Nakagawara A: p53: The
attractive tumor suppressor in the cancer research field. J Biomed
Biotechnol. 2011:6039252011. View Article : Google Scholar
|
|
10
|
Qi L and Zhang Y: Alisertib (MLN8237), a
selective Aurora-A kinase inhibitor, induces apoptosis in human
tongue squamous cell carcinoma cell both in vitro and in vivo.
Tumour Biol. Nov 4–2014.Epub ahead of print. View Article : Google Scholar
|
|
11
|
Yasumoto J, Imai Y, Takahashi A, Ohnishi
K, Yuki K, Kirita T and Ohnishi T: Analysis of apoptosis-related
gene expression after X-ray irradiation in human tongue squamous
cell carcinoma cells harboring wild-type or mutated p53 gene. J
Radiat Res. 44:41–45. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nagler RM, Kerner H, Laufer D, Ben-Eliezer
S, Minkov I and Ben-Itzhak O: Squamous cell carcinoma of the
tongue: The prevalence and prognostic roles of p53, Bcl-2, c-erbB-2
and apoptotic rate as related to clinical and pathological
characteristics in a retrospective study. Cancer Lett. 186:137–150.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Niu XW, Feng J, Peng ZH, et al:
Receptor-related mechanism of proliferation inhibilion and
apoptosis induetion of human tongue squamous cell line Tca8113 by
retinoids. Di Yi Jun Yi Da Xue Xue Bao. 25:935–941. 2005.PubMed/NCBI
|
|
14
|
Saleh HA, Jackson H, Khatib G and Banerjee
M: Correlation of bcl-2 oncoprotein immunohistochemical expression
with proliferation index and histopathologic parameters in
colorectal neoplasia. Pathol Oncol Res. 5:273–279. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie X, Clausen OP, De Angelis P and Boysen
M: The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and
p53 in oral squamous cell carcinoma of the tongue. Cancer.
86:913–920. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yeh CB, Su CJ, Hwang JM and Chou MC:
Therapeutic effects of cantharidin analogues without bridging ether
oxygen on human hepatocellular carcinoma cells. Eur J Med Chem.
45:3981–3985. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barr AC, Wigle WL, Flory W, Alldredge BE
and Reagor JC: Cantharidin poisoning of emu chicks by ingestion of
Pyrota insulata. J Vet Diagn Invest. 10:77–79. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hsia TC, Lin JH, Hsu SC, Tang NY, Lu HF,
Wu SH, Lin JG and Chung JG: Cantharidin induces DNA damage and
inhibits DNA repair-associated protein levels in NCI-H460 human
lung cancer cells. Environ Toxicol. Mar 17–2014.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C, Chen Z, Zhou X, Xu W, Wang G,
Tang X, Luo L, Tu J, Zhu Y, Hu W, et al: Cantharidin induces
G2/M phase arrest and apoptosis in human gastric cancer
SGC-7901 and BGC-823 cells. Oncol Lett. 8:2721–2726.
2014.PubMed/NCBI
|
|
20
|
Wang K, Lin C, Wang C, Shao Q, Gao W, Song
B, Wang L, Song X, Qu X and Wei F: Silencing Kif2a induces
apoptosis in squamous cell carcinoma of the oral tongue through
inhibition of the PI3K/Akt signaling pathway. Mol Med Rep.
9:273–278. 2014.
|
|
21
|
Fang QG, Shi S, Liu FY and Sun CF: Tongue
squamous cell carcinoma as a possible distinct entity in patients
under 40 years old. Oncol Lett. 7:2099–2102. 2014.PubMed/NCBI
|
|
22
|
Hsia TC, Yu CC, Hsu SC, Tang NY, Lu HF,
Huang YP, Wu SH, Lin JG and Chung JG: Cantharidin induces apoptosis
of H460 human lung cancer cells through mitochondria-dependent
pathways. Int J Oncol. 45:245–254. 2014.PubMed/NCBI
|
|
23
|
Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J,
Yang Q, Xu Y and Li F: Aberrant expression of microRNAs in gastric
cancer and biological significance of miR-574-3p. Int
Immunopharmacol. 13:468–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu M, Liu J, Wang L, Wu H, Zhou C, Zhu H,
Xu N and Xie Y: Association of serum microRNA expression in
hepatocellular carcinomas treated with transarterial
chemoembolization and patient survival. PLoS One. 9:e1093472014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee HP, Li TM, Tsao JY, Fong YC and Tang
CH: Curcumin induces cell apoptosis in human chondrosarcoma through
extrinsic death receptor pathway. Int Immunopharmacol. 13:163–169.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marx J: New tumor suppressor may rival
p53. Science. 264:344–345. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuo JH, Chu YL, Yang JS, Lin JP, Lai KC,
Kuo HM, Hsia TC and Chung JG: Cantharidin induces apoptosis in
human bladder cancer TSGH 8301 cells through mitochondria-dependent
signal pathways. Int J Oncol. 37:1243–1250. 2010.PubMed/NCBI
|
|
28
|
Saigusa S, Inoue Y, Tanaka K, Okugawa Y,
Toiyama Y, Uchida K, Mohri Y and Kusunoki M: Lack of M30 expression
correlates with factors reflecting tumor progression in rectal
cancer with preoperative chemoradiotherapy. Mol Clin Oncol.
2:99–104. 2014.PubMed/NCBI
|
|
29
|
Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y,
Xu Z and Han X: Cantharidin, a potent and selective PP2A inhibitor,
induces an oxidative stress-independent growth inhibition of
pancreatic cancer cells through G2/M cell-cycle arrest and
apoptosis. Cancer Sci. 101:1226–1233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huan SK, Lee HH, Liu DZ, Wu CC and Wang
CC: Cantharidin-induced cytotoxicity and cyclooxygenase 2
expression in human bladder carcinoma cell line. Toxicology.
223:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang WD, Zhao HR, Yan Y, Wang XH, Zong ZH
and Liu Y: Apoptosis induced by cantharidin in human pulmonary
carcinoma cells A549 and its molecular mechanisms. Zhonghua Zhong
Liu Za Zhi. 27:330–334. 2005.PubMed/NCBI
|
